Quick Answer
Nasus Pharma Ltd reported Stockholders Equity of $2.77 million for fiscal year 2025.
Nasus Pharma Ltd Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $2.77M | +186.2% |
| 2024 | -$3.21M | +15.4% |
| 2023 | -$3.80M | -36.3% |
| 2022 | -$2.79M | — |
- Nasus Pharma Ltd showed an increase of +186.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2025 period, Nasus Pharma Ltd’s stockholders equity has grown by 199.4% (from -$2.79 million to $2.77 million).
- The most recent figure is from Nasus Pharma Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: